Using it past this date can lead to reduced effectiveness and potential safety risks
Bendotti, G., Montefusco, L., Lunati, M
2 The safety results from the Phase 2b study are positive and suggest that the addition of enobosarm to semaglutide treatment doesnt worsen, and in some cases appears to improve gastrointestinal side effects, Louis J
Thats where prescription medicine for weight loss , like GLP-1s, comes in targeting appetite, cravings, and energy balance from the inside out
Once on these medications, you will likely need to stay on them the rest of your life to keep the weight from returning
The recommendation surprised many observers